Home Compare ALK-B.CO vs NOVN.SW
Stock Comparison · Single-driver result

ALK-Abelló A/S vs Novartis: Which Stock Looks Stronger in 2026?

Structurally, ALK-Abelló A/S and Novartis are closely matched — neither holds a meaningful edge overall. Novartis still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

On growth, the clearer edge sits with ALK-Abelló A/S, while the broader score remains level.

Trajectory Similarity
0.74
Similar
Peer-set rank: #4
within ALK-Abelló A/S's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The match is driven mainly by margin trend and revenue growth trajectory.

Similarity drivers
margin trendrevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
ALK-B.CO
ALK-Abelló A/S
55
Peer-Score
Signal qualityHigh
vs
NOVN.SW
Novartis AG
55
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: ALK-B.CO vs NOVN.SW Profitability 64 60 Stability 48 78 Valuation 38 55 Growth 76 22 ALK-B.CO NOVN.SW
Gap Ranking
#1 Growth +54
#2 Stability +30
#3 Valuation +17
#4 Profitability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ALK-B.CO and NOVN.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ALK-B.CONOVN.SW Relative valuation Structural strength

ALK-Abelló A/S looks stronger, but the price setup still looks more supportive for Novartis AG.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, ALK-Abelló A/S ranks near the top of the group; Novartis AG sits in the weaker half.
Stability
On stability, the edge is clear — both rank well, but Novartis AG sits noticeably higher.
Growth — Dominant Gap
ALK-B.CO
76
NOVN.SW
22
Gap+54in favour of ALK-B.CO

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

A meaningful counterforce remains in stability, which keeps the comparison from looking completely one-sided.

What this means for the comparison

Growth provides the clearer read here, while the broader score remains level.

Explore full peer positioning in AssetNext

Break down the ALK-B.CO vs NOVN.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how ALK-B.CO and NOVN.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.